403 related articles for article (PubMed ID: 27957795)
1. Refining anti-inflammatory therapy strategies for bronchopulmonary dysplasia.
Rudloff I; Cho SX; Bui CB; McLean C; Veldman A; Berger PJ; Nold MF; Nold-Petry CA
J Cell Mol Med; 2017 Jun; 21(6):1128-1138. PubMed ID: 27957795
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia.
Nold MF; Mangan NE; Rudloff I; Cho SX; Shariatian N; Samarasinghe TD; Skuza EM; Pedersen J; Veldman A; Berger PJ; Nold-Petry CA
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14384-9. PubMed ID: 23946428
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension.
Bui CB; Kolodziej M; Lamanna E; Elgass K; Sehgal A; Rudloff I; Schwenke DO; Tsuchimochi H; Kroon MAGM; Cho SX; Maksimenko A; Cholewa M; Berger PJ; Young MJ; Bourke JE; Pearson JT; Nold MF; Nold-Petry CA
Front Immunol; 2019; 10():1480. PubMed ID: 31354700
[TBL] [Abstract][Full Text] [Related]
4. Airway Remodeling and Hyperreactivity in a Model of Bronchopulmonary Dysplasia and Their Modulation by IL-1 Receptor Antagonist.
Royce SG; Nold MF; Bui C; Donovan C; Lam M; Lamanna E; Rudloff I; Bourke JE; Nold-Petry CA
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):858-868. PubMed ID: 27482635
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-33 (IL-33) Increases Hyperoxia-Induced Bronchopulmonary Dysplasia in Newborn Mice by Regulation of Inflammatory Mediators.
Tang X
Med Sci Monit; 2018 Sep; 24():6717-6728. PubMed ID: 30244258
[TBL] [Abstract][Full Text] [Related]
6. Iloprost attenuates hyperoxia-mediated impairment of lung development in newborn mice.
Olave N; Lal CV; Halloran B; Bhandari V; Ambalavanan N
Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L535-L544. PubMed ID: 29952221
[TBL] [Abstract][Full Text] [Related]
7. Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure.
Velten M; Heyob KM; Rogers LK; Welty SE
J Appl Physiol (1985); 2010 May; 108(5):1347-56. PubMed ID: 20223995
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 balance in the lungs of preterm infants who develop bronchopulmonary dysplasia.
Kakkera DK; Siddiq MM; Parton LA
Biol Neonate; 2005; 87(2):82-90. PubMed ID: 15539764
[TBL] [Abstract][Full Text] [Related]
9. Chitin-Derived AVR-48 Prevents Experimental Bronchopulmonary Dysplasia (BPD) and BPD-Associated Pulmonary Hypertension in Newborn Mice.
Das P; Acharya S; Prahaladan VM; Kumova OK; Malaeb S; Behera S; Agarwal B; Christensen DJ; Carey AJ; Bhandari V
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445253
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of β-catenin signaling improves alveolarization and reduces pulmonary hypertension in experimental bronchopulmonary dysplasia.
Alapati D; Rong M; Chen S; Hehre D; Hummler SC; Wu S
Am J Respir Cell Mol Biol; 2014 Jul; 51(1):104-13. PubMed ID: 24484510
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Rac1 Signaling Downregulates Inflammasome Activation and Attenuates Lung Injury in Neonatal Rats Exposed to Hyperoxia.
Hummler JK; Dapaah-Siakwan F; Vaidya R; Zambrano R; Luo S; Chen S; Kerr N; de Rivero Vaccari JP; Keane RW; Dietrich WD; Bancalari E; Young KC; Wu S
Neonatology; 2017; 111(3):280-288. PubMed ID: 28013306
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole Attenuates Pulmonary Aryl Hydrocarbon Receptor Activation and Potentiates Hyperoxia-Induced Developmental Lung Injury in Newborn Mice.
Shivanna B; Zhang S; Patel A; Jiang W; Wang L; Welty SE; Moorthy B
Toxicol Sci; 2015 Nov; 148(1):276-87. PubMed ID: 26272953
[TBL] [Abstract][Full Text] [Related]
13. Exogenous hydrogen sulfide (H2S) protects alveolar growth in experimental O2-induced neonatal lung injury.
Vadivel A; Alphonse RS; Ionescu L; Machado DS; O'Reilly M; Eaton F; Haromy A; Michelakis ED; Thébaud B
PLoS One; 2014; 9(3):e90965. PubMed ID: 24603989
[TBL] [Abstract][Full Text] [Related]
14. Intermittent hypoxia during recovery from neonatal hyperoxic lung injury causes long-term impairment of alveolar development: A new rat model of BPD.
Mankouski A; Kantores C; Wong MJ; Ivanovska J; Jain A; Benner EJ; Mason SN; Tanswell AK; Auten RL; Jankov RP
Am J Physiol Lung Cell Mol Physiol; 2017 Feb; 312(2):L208-L216. PubMed ID: 27913427
[TBL] [Abstract][Full Text] [Related]
15. PC (16:0/14:0) ameliorates hyperoxia-induced bronchopulmonary dysplasia by upregulating claudin-1 and promoting alveolar type II cell repair.
Hou W; Yu B; Li Y; Yan X; Su Q; Fang X; Zhou X; Yu Z
Int J Biochem Cell Biol; 2024 Jul; 172():106587. PubMed ID: 38740281
[TBL] [Abstract][Full Text] [Related]
16. Ginger ( Zingiber officinale ) prevents severe damage to the lungs due to hyperoxia and inflammation.
Çifci A; Tayman C; Yakut Hİ; Halil H; Çakır E; Çakır U; Aydemir S
Turk J Med Sci; 2018 Aug; 48(4):892-900. PubMed ID: 30121057
[TBL] [Abstract][Full Text] [Related]
17. The Role of the Interleukin-1 Family in Complications of Prematurity.
Green EA; Garrick SP; Peterson B; Berger PJ; Galinsky R; Hunt RW; Cho SX; Bourke JE; Nold MF; Nold-Petry CA
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769133
[TBL] [Abstract][Full Text] [Related]
18. L-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats.
Vadivel A; Aschner JL; Rey-Parra GJ; Magarik J; Zeng H; Summar M; Eaton F; Thébaud B
Pediatr Res; 2010 Dec; 68(6):519-25. PubMed ID: 20805789
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats.
de Visser YP; Walther FJ; Laghmani el H; Steendijk P; Middeldorp M; van der Laarse A; Wagenaar GT
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(1):L56-67. PubMed ID: 21949154
[TBL] [Abstract][Full Text] [Related]
20. Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental Bronchopulmonary Dysplasia.
Hirsch K; Taglauer E; Seedorf G; Callahan C; Mandell E; White CW; Kourembanas S; Abman SH
Am J Respir Crit Care Med; 2020 Oct; 202(8):1146-1158. PubMed ID: 32551816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
